This study investigates the effects of radiotherapy on the tumor microenvironment in patients with cervical and pancreatic cancer. It collects various biospecimens and treatment-related data to understand the biological changes during treatment.
The study evaluates how radiotherapy impacts the safety and effectiveness of the treatment by analyzing biological samples and imaging data. This study seeks to provide insights into the treatment process for these cancers.
- Who can participate: Adults aged 18 and older with a confirmed diagnosis of cervical or pancreatic cancer planning to receive radiotherapy can participate. Participants must have an ECOG performance status of 2 or less and be able to provide informed consent.
- Study details: Participants will provide biospecimens such as blood and tissue samples before, during, and after their radiotherapy treatment to understand the effects on the body.
How understandable was the trial content above?
Hard to understand
Easy to understand